Ask Warren

Hwail Pharm

061250 · KOSDAQ · ₩061250 · 화일약품

₩5,600▼ ₩150 (2.61%)End-of-day · Oct 30, 2026 · End-of-day prices.
Trade
Alert me
SellBuy
AnnualQuarterly

Income statement

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Revenue₩24B₩23B₩19B₩24B₩28B₩30B₩27B₩30B
Cost of sales₩22B₩21B₩18B₩22B₩26B₩28B₩24B₩27B
Gross profit₩2B₩2.4B₩367M₩2.2B₩2B₩2.1B₩2.3B₩2.6B
Operating income−₩912M−₩566M−₩1.3B₩165M₩51M−₩1.2B−₩411M₩140M
Net income₩3.8B₩579M−₩621M−₩163M₩1.2B−₩657M₩6.4B₩633M
Net income to shareholders₩4.4B₩579M−₩621M−₩163M₩1.2B−₩657M₩6.4B₩633M

Balance sheet

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Total assets₩222B₩215B₩213B₩213B₩217B₩216B₩216B₩201B
Current assets₩137B₩140B₩131B₩128B₩131B₩134B₩134B₩129B
Cash and equivalents₩71B₩66B₩61B₩59B₩53B₩54B₩54B₩59B
Total liabilities₩8.6B₩6.3B₩6.3B₩5.3B₩7.9B₩14B₩12B₩11B
Current liabilities₩8B₩6B₩6B₩5B₩7.3B₩13B₩12B₩11B
Borrowings——₩0—₩331M₩4.3B₩4.2B₩3.8B
Total equity₩213B₩209B₩207B₩208B₩209B₩203B₩203B₩190B
Shareholders' equity₩213B₩209B₩207B₩208B₩209B₩203B₩203B₩190B

Cash flow

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Cash from operations₩3.8B−₩4.6B₩4.1B₩6.8B₩565M₩386M₩10B₩1.9B
Capital spending₩232M₩361M₩1.2B₩1.4B₩1.1B₩228M₩11B₩14B
Free cash flow₩3.5B−₩4.9B₩2.9B₩5.4B−₩566M₩157M−₩425M−₩13B

Consolidated where available. Amounts in won.

Also known as: Hwail Pharm / 화일약품 / 061250 / KRX:061250

Source: KRX statistical information